Pityrosporum ovale appears to play an important role in the pathogenesis of seborrhoeic
dermatitis.
Ketoconazole is an antimycotic agent with a high in vitro and in vivo efficacy against P. ovale. We performed a multicentre study to investigate the efficacy of
ketoconazole 2% shampoo in the treatment and prophylaxis of seborrhoeic
dermatitis and
dandruff. Five hundred and seventy-five patients presenting with moderate to severe seborrhoeic
dermatitis and
dandruff of the scalp were treated with 2%
ketoconazole shampoo twice weekly for 2-4 weeks, producing an excellent response in 88%. Of those patients who responded, 312 were included in a prophylactic phase, lasting 6 months. These patients were treated with the active preparation (shampoo containing 2%
ketoconazole) once-weekly, once every other week, alternating with placebo (shampoo without
ketoconazole), or with placebo only once-weekly. Forty-eight (47%) patients in the placebo group experienced a relapse of seborrhoeic
dermatitis, compared with 23 (19%) patients in the active treatment group, and 31 (31%) patients in the active/placebo group. The medication was well tolerated in all three groups. We conclude that
ketoconazole 2% shampoo is highly effective, not only in clearing scalp seborrhoeic
dermatitis and
dandruff, but also in preventing relapse of the disease when used prophylactically once weekly.